• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝移植的麻醉学相关方面]

[Anesthesiological aspects of liver transplantation].

作者信息

Dehne S, Lund F, Larmann J, Schmidt K, Brenner T, Weigand M A, von Haken R

机构信息

Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland.

出版信息

Anaesthesist. 2019 Jun;68(6):403-418. doi: 10.1007/s00101-019-0595-x.

DOI:10.1007/s00101-019-0595-x
PMID:31049602
Abstract

Liver transplantation (LTPL) is the only curative option for patients with end stage liver disease (ESLD) or with hepatocellular carcinoma (HCC). Eurotransplant in Leiden, the Netherlands, is responsible for organ allocation. The model of end stage liver disease (MELD) score, which describes the severity of the liver disease, is decisive for organ allocation. The heterogeneous patient collective and hepatic-related comorbidities and their dynamics represent challenges. The anesthesiologist is responsible for evaluating the overall prognosis, whereby cardiac, pulmonary, renal and neurological comorbidities must be taken into consideration. During LTPL surgery is divided into several stages. Besides volume management, heat preservation and coagulation management, major challenges for the anesthesiologist are hemodynamic stabilization and regulation of the acid-base balance.

摘要

肝移植(LTPL)是终末期肝病(ESLD)或肝细胞癌(HCC)患者的唯一治愈选择。位于荷兰莱顿的欧洲移植组织负责器官分配。终末期肝病模型(MELD)评分描述了肝病的严重程度,对器官分配起决定性作用。患者群体的异质性以及肝脏相关的合并症及其动态变化构成了挑战。麻醉医生负责评估总体预后,必须考虑心脏、肺部、肾脏和神经方面的合并症。在肝移植手术过程中分为几个阶段。除了容量管理、保温和凝血管理外,麻醉医生面临的主要挑战是血流动力学稳定和酸碱平衡的调节。

相似文献

1
[Anesthesiological aspects of liver transplantation].[肝移植的麻醉学相关方面]
Anaesthesist. 2019 Jun;68(6):403-418. doi: 10.1007/s00101-019-0595-x.
2
MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.MELDEQ:一种用于肝细胞癌患者的终末期肝病评分替代模型。
Liver Transpl. 2015 May;21(5):612-22. doi: 10.1002/lt.24098. Epub 2015 Apr 15.
3
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.一种在共同的肝移植等待名单上为肝癌患者和非肝癌患者分配公平性的方法。
J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23.
4
Liver transplantation in Germany.德国的肝移植
Liver Transpl. 2016 Aug;22(8):1136-42. doi: 10.1002/lt.24461.
5
Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.基于肿瘤特征和动态的新型肝癌 MELD 例外评分系统的提出。
J Hepatol. 2017 Feb;66(2):374-381. doi: 10.1016/j.jhep.2016.10.008. Epub 2016 Oct 15.
6
Model for End-Stage Liver Disease-Sodium Score: The Evolution in the Prioritization of Liver Transplantation.终末期肝病-钠评分模型:肝移植优先级的演变
Clin Liver Dis. 2017 May;21(2):275-287. doi: 10.1016/j.cld.2016.12.014.
7
Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?肝细胞癌患者心源性死亡后的捐赠:适应证相同吗?
Liver Transpl. 2017 Oct;23(S1):S27-S33. doi: 10.1002/lt.24862.
8
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.七十岁以上患者接受终末期肝病模型例外点用于肝细胞癌的肝移植:全国经验。
Liver Transpl. 2012 Apr;18(4):423-33. doi: 10.1002/lt.23385.
9
Liver transplantation for hepatocellular carcinoma: the MELD impact.肝细胞癌的肝移植:终末期肝病模型(MELD)的影响
Liver Transpl. 2004 Jan;10(1):36-41. doi: 10.1002/lt.20012.
10
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.肝细胞癌的肝移植:终末期肝病模型(MELD)分配系统的影响及生存预测因素
Gastroenterology. 2008 May;134(5):1342-51. doi: 10.1053/j.gastro.2008.02.013. Epub 2008 Feb 13.

本文引用的文献

1
Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU.对入住重症监护病房的肝硬化患者急性肾损伤肝肾综合征标准的评估。
Scand J Gastroenterol. 2018 Dec;53(12):1590-1596. doi: 10.1080/00365521.2018.1545423. Epub 2019 Jan 8.
2
Blood Product Transfusion in Liver Transplantation and its Impact on Short-term Survival.肝移植中的血液制品输注及其对短期生存的影响。
Int J Organ Transplant Med. 2018;9(3):105-111. Epub 2018 Aug 1.
3
Coagulopathy during liver transplantation.肝移植期间的凝血功能障碍。
J Anaesthesiol Clin Pharmacol. 2018 Jul-Sep;34(3):289-295. doi: 10.4103/joacp.JOACP_390_16.
4
Piggyback or Cava Replacement: Which Implantation Technique Protects Liver Recipients From Acute Kidney Injury and Complications?背驮式或腔静脉置换:哪种植入技术能保护肝受体免受急性肾损伤及并发症的影响?
Liver Transpl. 2018 Dec;24(12):1746-1756. doi: 10.1002/lt.25334.
5
Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report.体外膜肺氧合在肝移植严重心脏循环功能障碍受者中的应用:一例报告
Medicine (Baltimore). 2018 Sep;97(37):e12407. doi: 10.1097/MD.0000000000012407.
6
Cirrhotic cardiomyopathy.肝硬化性心肌病
J Hepatol. 2018 Oct;69(4):958-960. doi: 10.1016/j.jhep.2018.01.006. Epub 2018 Apr 30.
7
Comparison of the WarmCloud and Bair Hugger Warming Devices for the Prevention of Intraoperative Hypothermia in Patients Undergoing Orthotopic Liver Transplantation: A Randomized Clinical Trial.温云与拜尔暖风机预防原位肝移植患者术中低体温的比较:一项随机临床试验
Transplant Direct. 2018 Mar 20;4(4):e358. doi: 10.1097/TXD.0000000000000775. eCollection 2018 Apr.
8
Incidence and clinical significance of hyperfibrinolysis during living donor liver transplantation.活体肝移植期间高纤溶状态的发生率及临床意义
Blood Coagul Fibrinolysis. 2018 Apr;29(3):322-326. doi: 10.1097/MBC.0000000000000733.
9
Neurologic Considerations and Complications Related to Liver Transplantation.肝移植相关的神经学考量与并发症
Anesthesiology. 2018 May;128(5):1008-1014. doi: 10.1097/ALN.0000000000002148.
10
Neurological complications of solid organ transplantation.实体器官移植的神经系统并发症
Arq Neuropsiquiatr. 2017 Oct;75(10):736-747. doi: 10.1590/0004-282X20170132.